Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» XenoPort and Glaxo says FDA review of neuropathic pain drug extended 3 months, to Feb. 2010
XenoPort and Glaxo says FDA review of neuropathic pain drug extended 3 months, to Feb. 2010
XenoPort and Glaxo says FDA review of neuropathic pain drug extended 3 months, to Feb. 2010
Submitted by
admin
on November 9, 2009 - 10:09am
Source:
Yahoo/AP
News Tags:
XenoPort
FDA
GSK
neuropathic pain
Headline:
XenoPort and Glaxo says FDA review of neuropathic pain drug extended 3 months, to Feb. 2010
Do Not Allow Advertisers to Use My Personal information
